On the occasion of the Attd Congress that is celebrated in Milan these days, Roche Diabetes Care has presented a series of studies on the control solutions of interactive diabetes and cloud -based that today are available to the person with diabetes such asThe Emminens case.Cloud solutions that allow patients to devote less time to their daily activities related to diabetes and have a greater quality of life.

Today, everyone is connected through mobile phones, tablets and computers, practically everywhere and at all times.At present, solutions for the treatment and remote monitoring of patients account for almost 60 % of all mobile health systems in Europe.But are we taking full advantage of all the potential we have at our disposal to benefit people with diabetes?


Often, people with diabetes feel insecure and uncomfortable in relation to their daily therapeutic routine.In addition, many are concerned to suffer hypoglycemia episodes for making an error in insulin administration or skipping glycemia measurements, as important, for different reasons such as lack of time or the absence of privacy.

One of the most common challenges for caregivers and diabetologists is the availability and quality of diabetes data.There are studies that show that only half of the daily records of adult diabetics can be considered precise and reliable.On the other hand, patients often forget to keep their record with them when they go to the doctor.This makes the professional receive incomplete information, so that both the consultation and analysis of the data as well as the treatment settings are difficult and consume a lot of time, when they are not directly impossible.

the accu-chek bolus calculator

Another important problem that must be addressed in this context is the difficulty of patients to make decisions about daily treatment - like the adjustment of the insulin dose - in the course of their usual activities.Many people with diabetes have difficulty calculating the dose of the insulin bolus associated with a meal or a snack.An incorrect insulin dose can cause dangerous episodes of short -term hypoglycemia and more serious long -term complications.Numerous studies have shown that the use of bolus automatic calculator technology can have significant advantages for insulin diabetics.

The most recent data from the Steno ABC study, presented by Dr. Kirsten Nørgaard, an endocrinologist at the Hivvre University Hospital (Denmark), show that an automatic bolus calculator can substantially improve insulin administration contributing to reduce the concentration of HBA1C andAchieve better general glycemic control, with less fluctuations and lower risk of hypoglycemia episodes."I have seen that patients who use the ACCU-Chek bolus calculator perceive this system as a great help and consider it useful and easy to handle," says Dr. Nørgaard, "in general, we also verify that patients not only trustedRecommendations of the bolus calculator, but they learned from them and thus improved their abilities over time ».Therefore, this specialist considers that the tool helps educate patients and improve their competence when counting carbohydrates and calculate bowling.

Emminens Econecta's app

Examining in more detail how modern therapeutic approaches can strengthen links between diabetic patients and health professionals to make faster therapeutic decisions and with aMore solid basis, Dr. Concetta Irace-Associate Professor of Technology and Medical Sciences at the Magna Graecia University of Catanzaro (Italy) since 2015-cited as an example the innovative ACCU-Chek Connect system, which consists of the ACCU-Chek Aviva Connect Gluccometer Connect, an application for mobile devices and a web portal that people with diabetes and health professionals can access: «It is a revolutionary tool that connects all the people involved in the optimal control of diabetes.The system has radically changed the role of the glucometer, because it gives a meaning to the figures and helps me as a doctor and the healthcare personnel to be close to our patients and help them whenever our advice need.

Dr. Irace presented the most recent results of the ACCRUES and ACCU-Chek Connect Friends studies.Both studies show that the use of the ACCU-Chek Connect system causes the interpretation of blood glucose results to be faster and more reliable.In addition, the system also proved to be useful for educating patients.The majority of the participants considered that the learning and use of the system were very easy.And, more importantly, that the system helped them better control their diabetes.In addition, it transmitted more confidence and security and reduced their fear of possible hypoglycemia.Dr. Irara concluded: «The ACCU-Chek Connect system is a great technology that we had been waiting for a long time.In my daily work it helps me and my patients to overcome many of the barriers that still prevent good metabolic control, and save time by allowing us to resort to all communication channels and not only the visit in the office ».

In Spain, Emminens has recently launched the Econecta app.The mobile application for people with diabetes aims to improve the control of their disease and increase their autonomy in the day to day.The application, free and downloadable in Play Store and Apple Store, is indicated for all those who have been registered on the Emminens platform Econecta by their health professional.

Roche in Milan

The development of apps such as the one presented by Emminens responds, according to Lars Kalfhaus, general director of Emminens Healthcare Services, “to the need to continue working to get the passage of a traditional health system to a digital health model, since it is keyto respond to the growing number of people suffering from chronic diseases in the world.The benefits of this new model affect both better information and decision -making and the patient's quality of life, as well as savings for both families and the health system. ”

Thanks to this new app, people with diabetes can have all data and review them through different graphics: from the last 7, 14, 30 and 90 days, to daily and weekly evolution, as well as the record of data from data from data frominsulin and health events.In addition, it offers educational content to self -manage the disease more effectively and, thus, achieve greater adherence to treatments.

The evolution of integrated personalized control of diabetes

«The results of these studies and individual experiences, as well as the valuations we have received from diabetics and those who treat them, clearly indicate that our integrated approach for personalized control of diabetes, as well as the solutions we provide to put it to put itIn practice, they are already having a very positive impact on the daily control of diabetes, ”said Dr. Matthias Axel Schweitzer, International Director of Medical and Scientific Affairs and Medical Director of Roche Diabetes Care.In hisIntervention alluded to the evolution of the integrated approach to personalized diabetes control.«There are already promising data that demonstrate the advantages of each of the steps of the integrated concept of personalized diabetes control, also applied through Cibersalud solutions such as the ACCU-Chek Connect system or the Emminens Econecta platform.We are convinced that our company can not only provide value through better therapeutic results, but also contribute to improving health structures ».

Dr. Schweitzer thus summed up his conclusions: «We will continue to promote innovative and integrated solutions that facilitate optimal and efficient treatment to all people with diabetes minimize the load that this chronic disease supposes for patients and family members.Our goal is to help diabetics to worry about their daily activities related to diabetes.At the same time, we aspire to take advantage of the potential of personalized control integrated in combination with CIBERSALUD to help a more efficient sustainable use of health budgets ».

about the personalized control of diabetes

At present, in the control of diabetes, an increasing degree of customization is attended, with a great emphasis on the glycemic profile of each patient and an increasing awareness of the importance of glycemic variability when preventingLate complications such as cardiovascular diseases.Therefore, Roche Diabetes Care is investigating new ways for a more effective treatment control.

In addition, the company develops integrated concepts that offer efficient solutions to analyze individual glycemic patterns and provide data that improve feedback loops, allow effective and grounded decisions to be made and facilitate dialogue between the doctor and the patient.We are convinced that a better integration of the relevant therapeutic aspects for the patient is greater therapeutic motivation and compliance, and therefore better treatment results.Roche Diabetes Care works with great dedication to make control of medically effective diabetes applying the concept of personalized control of diabetes and providing all the necessary components for its implementation.